A carregar...
Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines
Aim: It is known that botulinum neurotoxin type A (BoNTA) improves some kinds of cancer (e.g. prostate) and that synaptic vesicle glycoprotein 2 (SV2) is the molecular target of this neurotoxin. Besides having potential therapeutic value, this glycoprotein has recently been proposed as a molecular m...
Na minha lista:
| Publicado no: | Int J Clin Exp Pathol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4555739/ https://ncbi.nlm.nih.gov/pubmed/26339411 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|